The medicine is the same, the packaging and quality control are not
The opportunity lies in the hands of dedicated researchers looking to unlock the full potential of compounds like BPC 157 and other novel peptides
These medications mimic glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces
Robert Kushner, MD, MS, professor of medicine and medicine education at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, sat down with Drug Topics ahead of the American Society for Preventive Cardiology Congress on CVD Prevention to discuss the benefits of glucagon-like peptide-1 (GLP-1) therapies and highlighted some strategies for management of adverse effects
For instance, the medication slows down how quickly your stomach empties, so eating heavy, fatty foods might lead to discomfort